PDE5A and diabetes mellitus: While PDE5 inhibitors are commonly used as the first-line treatment for ED, alprostadil is mainly used for patients with severe ED who display resistance to PDE5 inhibitors, ED related to neuronal damage from diabetes, or non-nerve-sparing pelvic surgery, and individuals with contradictions of PDE5 inhibitors [15].